Trulicity alternatives — what to ask your prescriber

Therapeutic alternatives, by category

Equivalence strength reflects shared mechanism of action plus the depth of head-to-head clinical evidence. Costs are US cash-price estimates and vary widely by pharmacy, insurance, and manufacturer copay programs.

FAQ

Is there a generic version of Trulicity?

No. There is no FDA-approved generic dulaglutide as of 2026. Dulaglutide is an Fc-fusion peptide; composition-of-matter patents extend into the late 2020s. Because dulaglutide is a larger fusion protein it is more biologic-like than the smaller GLP-1 peptides — generic / follow-on biologic pathway is less certain.

When will generic Trulicity be available?

Estimated US generic availability: ~2027-2029. This is an estimate based on USPTO Orange Book exclusivity and composition-of-matter patent expiry. Dulaglutide is an Fc-fusion peptide; composition-of-matter patents extend into the late 2020s. Because dulaglutide is a larger fusion protein it is more biologic-like than the smaller GLP-1 peptides — generic / follow-on biologic pathway is less certain.

Is compounded dulaglutide the same as a generic?

No. Compounded products are prepared by licensed compounding pharmacies and are NOT FDA-approved as finished drugs. They have not undergone FDA bioequivalence testing and are not legally substitutable the way a true ANDA-approved generic would be.

Can I switch from Trulicity to one of these alternatives on my own?

No. Switching GLP-1 medications requires a prescriber's clinical judgment about your indication, dose-titration history, side-effect tolerance, and insurance coverage. The alternatives listed here are options to DISCUSS with your prescriber — not recommendations.